您的当前位置:首页 > 行业数据 > 基于PD-1/PD-L1的联合疗法开发趋势(左侧为联合用药靶点,右侧为主靶点)
图片属性
图片格式:PNG 图片大小:1340KB 图片尺寸:1852*1521
同报告图片
 / 4
基于PD-1/PD-L1的联合疗法开发趋势(左侧为联合用药靶点,右侧为主靶点)_第1页
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
基于PD-1/PD-L1的联合疗法开发趋势(左侧为联合用药靶点,右侧为主靶点)_第2页
fCDlubTku70gICB8IOW4guWcuuinhOaooe+8iOWNgeS6v+S6uuawkeW4ge+8iSB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDE2ICAgfCAxMjUuMCAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTcgICB8IDEzOS40ICAgICAgICAgICAgICAgICAgICB8CnwgMjAxOCAgIHwgMTU3LjUgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE5ICAgfCAxODIuNyAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjAgICB8IDE5Ny41ICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMUUgIHwgMjQ0LjAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIyRSAgfCAyODQuNSAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjNFICB8IDMyNi4wICAgICAgICAgICAgICAgICAgICB8CnwgMjAyNEUgIHwgMzcxLjYgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI1RSAgfCA0MTYuMiAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjZFICB8IDQ2Ni4yICAgICAgICAgICAgICAgICAgICB8CnwgMjAyN0UgIHwgNTE2LjUgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI4RSAgfCA1NjkuNyAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjlFICB8IDYyNi43ICAgICAgICAgICAgICAgICAgICB8CnwgMjAzMEUgIHwgNjgzLjEgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuDIwMjTlubTlubTmiqXvvIzljY7mupDor4HliLjnoJTnqbbmiYA=
基于PD-1/PD-L1的联合疗法开发趋势(左侧为联合用药靶点,右侧为主靶点)_第3页
基于PD-1/PD-L1的联合疗法开发趋势(左侧为联合用药靶点,右侧为主靶点)_第4页
基于PD-1/PD-L1的联合疗法开发趋势(左侧为联合用药靶点,右侧为主靶点)_第5页
所属报告: 上海谊众(688091)-A股公司研究报告:紫杉醇胶束有望加速放量PD1三抗提供较大向上弹性-250923(19页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠